Amgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...
Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $329.00. The ...
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Amgen's whale ...
"Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP" was originally created and published by ...
Amgen released financial results for the 4th quarter of 2024. Check out why I continue to cover AMGN stock with a 'Buy' ...
U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...
Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...
The partners are building toward a regulatory submission for Tezspire in chronic rhinosinusitis with nasal polyps in the ...
Amgen Inc. (NASDAQ:AMGN – Get Free Report) was the target of some unusual options trading activity on Friday. Stock traders ...
Amgen (AMGN) and AstraZeneca (AZN) announced full results from the Phase 3, registrational WAYPOINT trial demonstrating that TEZSPIRE ...
Amgen (NASDAQ: AMGN) will present at the 45th Annual TD Cowen Health Care Conference at 9:10 a.m. ET on Wednesday, March 5, 2025. Jay Bradner, executive vice president of Research and Development at ...
La La Anthony is partnering with Amgen to raise awareness and support those struggling with plaque psoriasis. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback